• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC 0.00% 10.0¢

IMMURON LIMITED - Announcements

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The Company's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the counter orally administered passive immunotherapeutic product indicated to reduce the risk of travelers' diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. The Company has four clinical programs -Travelan (IMM-124E), CampETEC, IMM-529 and Travelan (consumer product).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


IMC Change in substantial holding30/04/24 download Created with Sketch. 643.75KB
IMC Immuron CEO Steven Lydeamore to present at The Watchlist23/04/24 download Created with Sketch. 1.83MB
IMC Immuron to host Live Virtual Event15/04/24 download Created with Sketch. 296.16KB
IMC Immuron Travelan sales continued strong growthPRICE SENSITIVE10/04/24 download Created with Sketch. 315.78KB
IMC Change in substantial holding22/03/24 download Created with Sketch. 1.51MB
IMC Notice under section 708A14/03/24 download Created with Sketch. 179.38KB
IMC Change of Director's Interest Notice (DP)14/03/24 download Created with Sketch. 168.99KB
IMC Application for quotation of securities - IMC14/03/24 download Created with Sketch. 16.05KB
IMC Immuron CEO, Steven Lydeamore to present at Coffee Microcaps14/03/24 download Created with Sketch. 1.29MB
IMC Change in substantial holding14/03/24 download Created with Sketch. 1.49MB
IMC Travelan to progress to Phase 3 Clinical Trials in the USPRICE SENSITIVE07/03/24 download Created with Sketch. 408.71KB
IMC Trading HaltPRICE SENSITIVE05/03/24 download Created with Sketch. 221.96KB
IMC Change in substantial holding01/03/24 download Created with Sketch. 1.52MB
IMC Appendix 4D and Half Year ReportPRICE SENSITIVE28/02/24 download Created with Sketch. 2.93MB
IMC Presentation to Australian Biologics Festival 202421/02/24 download Created with Sketch. 2.48MB
IMC Immuron achieves record Travelan salesPRICE SENSITIVE13/02/24 download Created with Sketch. 260.27KB
IMC Investor Webinar Presentation08/02/24 download Created with Sketch. 1.26MB
IMC Immuron achieves record half yearly Travelan salesPRICE SENSITIVE16/01/24 download Created with Sketch. 277.27KB
IMC Immuron Clinical Trials Update22/12/23 download Created with Sketch. 292.74KB
IMC First Patients Enrolled in Campylobacter Clinical StudyPRICE SENSITIVE04/12/23 download Created with Sketch. 303.92KB
IMC Investor Webinar Presentation28/11/23 download Created with Sketch. 1.51MB
IMC Change of Director's Interest Notice (PB)24/11/23 download Created with Sketch. 170.32KB
IMC Notification regarding unquoted securities - IMC24/11/23 download Created with Sketch. 25.45KB
IMC Amended Constitution22/11/23 download Created with Sketch. 463.37KB
IMC Results of Annual General Meeting21/11/23 download Created with Sketch. 134.97KB
IMC Presentation to Annual General Meeting21/11/23 download Created with Sketch. 774.11KB
IMC Investor Webinar Presentation13/11/23 download Created with Sketch. 1.66MB
IMC Immuron CEO, Steven Lydeamore to present at AusBioInvest30/10/23 download Created with Sketch. 1.36MB
IMC Notice of Annual General Meeting/Proxy Form23/10/23 download Created with Sketch. 424.96KB
IMC Travelan Clinical Study Cohort 2 commences18/10/23 download Created with Sketch. 303.18KB
IMC Immuron achieves record quarterly Travelan salesPRICE SENSITIVE11/10/23 download Created with Sketch. 279.1KB
IMC Immuron CEO, Steven Lydeamore to present at LD Micro04/10/23 download Created with Sketch. 1.46MB
IMC Appendix 4G28/09/23 download Created with Sketch. 263.25KB
IMC Corporate Governance Statement28/09/23 download Created with Sketch. 199.71KB
IMC Annual Report to shareholders28/09/23 download Created with Sketch. 4.04MB
IMC Immuron achieves record monthly Travelan salesPRICE SENSITIVE13/09/23 download Created with Sketch. 262.36KB
IMC Immuron CEO, Steven Lydeamore to present at H.C. Wainwright11/09/23 download Created with Sketch. 1.63MB
IMC Appendix 4E Preliminary Final ReportPRICE SENSITIVE30/08/23 download Created with Sketch. 2.14MB
IMC Immuron present to Military Health System Research Symposium14/08/23 download Created with Sketch. 453.76KB
IMC Immuron Receives TGA GMP ClearancePRICE SENSITIVE09/08/23 download Created with Sketch. 277.95KB
IMC Immuron enrols patients in Travelan clinical studyPRICE SENSITIVE25/07/23 download Created with Sketch. 303.58KB
IMC Immuron CEO, Steven Lydeamore to present at Bioshares24/07/23 download Created with Sketch. 1.65MB
IMC Notification regarding unquoted securities - IMC12/07/23 download Created with Sketch. 27.28KB
IMC Letter to Shareholders11/07/23 download Created with Sketch. 285.32KB
IMC Immuron FY23 Sales increase 136% on FY22 SalesPRICE SENSITIVE05/07/23 download Created with Sketch. 280.73KB
IMC Immuron Chairman Transition30/06/23 download Created with Sketch. 255.93KB
IMC Letter to Shareholders22/06/23 download Created with Sketch. 417.25KB
IMC Immuron CEO, Steven Lydeamore presents at LD Micro07/06/23 download Created with Sketch. 1.8MB
IMC Immuron Initiates Recruitment of Travelan Clinical StudyPRICE SENSITIVE30/05/23 download Created with Sketch. 297.14KB
IMC FDA Removed Clinical Hold on Campylobacter ETEC TherapeuticPRICE SENSITIVE08/05/23 download Created with Sketch. 295.07KB
IMC IMC CEO Steven Lydeamore to present at Coffee Microcaps02/05/23 download Created with Sketch. 998.52KB
IMC Q3 FY23 Business Update PresentationPRICE SENSITIVE19/04/23 download Created with Sketch. 866.7KB
IMC Q3 FY23 Business Update Webinar11/04/23 download Created with Sketch. 285.87KB
IMC Immuron Q3 Sales reach 150% of 1H SalesPRICE SENSITIVE06/04/23 download Created with Sketch. 262.26KB
IMC Notification of cessation of securities - IMC16/03/23 download Created with Sketch. 21.57KB
IMC Appendix 4D and Half Year ReportPRICE SENSITIVE28/02/23 download Created with Sketch. 2.8MB
IMC Business Update PresentationPRICE SENSITIVE28/02/23 download Created with Sketch. 746.36KB
IMC Immuron CEO Steven Lydeamore to host investor webinar15/02/23 download Created with Sketch. 211.84KB
IMC Immuron and US NMRC respond to CampETEC FDA Clinical Hold25/01/23 download Created with Sketch. 252.86KB
IMC US DOD Travelan Clinical Recruitment Milestone18/01/23 download Created with Sketch. 285.22KB
IMC Immuron Receives European Patent on Drug Composition17/01/23 download Created with Sketch. 352.58KB
IMC Change in substantial holding30/12/22 download Created with Sketch. 1.57MB
IMC Immuron Receives FDA Approval for Travelan IND ApplicationPRICE SENSITIVE23/12/22 download Created with Sketch. 285.59KB
IMC Immuron Submits IND Application To FDA for Travelan05/12/22 download Created with Sketch. 282.81KB
IMC Amended Constitution01/12/22 download Created with Sketch. 496.22KB
IMC Results of Annual General Meeting21/11/22 download Created with Sketch. 161.19KB
IMC AGM Presentation21/11/22 download Created with Sketch. 534.76KB
IMC Immuron completes strategic investment in Ateria HealthPRICE SENSITIVE16/11/22 download Created with Sketch. 323.13KB
IMC Immuron CEO Steven Lydeamore to present at AusBioInvest26/10/22 download Created with Sketch. 645.88KB
IMC Notice of Annual General Meeting/Proxy Form21/10/22 download Created with Sketch. 478.06KB
IMC IMC investment in leading gut health biotech Ateria HealthPRICE SENSITIVE13/10/22 download Created with Sketch. 343.35KB
IMC Immuron Executes Travelan Clinical Trial Agreement Pharmaron04/10/22 download Created with Sketch. 284.86KB
IMC Appendix 4G09/09/22 download Created with Sketch. 323.73KB
IMC Corporate Governance Statement09/09/22 download Created with Sketch. 201.39KB
IMC Annual Report to shareholders09/09/22 download Created with Sketch. 3.86MB
IMC FY22 Results and Business Update Presentation31/08/22 download Created with Sketch. 881.7KB
IMC Appendix 4E and Preliminary Final ReportPRICE SENSITIVE31/08/22 download Created with Sketch. 1.46MB
IMC Immuron CEO, Steven Lydeamore, to host an investor webinar29/08/22 download Created with Sketch. 281.17KB
IMC Immuron Update on IMM-124E SARS-CoV-2 ResearchPRICE SENSITIVE19/08/22 download Created with Sketch. 284.76KB
IMC Update on IND Application for Campylobacter ETEC Therapeutic26/07/22 download Created with Sketch. 285.31KB
IMC North American Travelan Sales up 494%, Global sales up 431%PRICE SENSITIVE11/07/22 download Created with Sketch. 258.28KB
IMC European Patent Notification on Drug Composition for CDIPRICE SENSITIVE07/07/22 download Created with Sketch. 388.35KB
IMC Change of Director's Interest Notice (DP)04/07/22 download Created with Sketch. 182.63KB
IMC Notification regarding unquoted securities - IMC01/07/22 download Created with Sketch. 25.37KB
IMC Change of Director's Interest Notice15/06/22 download Created with Sketch. 191.78KB
IMC Notification of cessation of securities - IMC14/06/22 download Created with Sketch. 21.61KB
IMC Notification of cessation of securities - IMC10/06/22 download Created with Sketch. 22.1KB
IMC Change in substantial holding25/05/22 download Created with Sketch. 889.62KB
IMC US DoD NMRC files IND application with FDAPRICE SENSITIVE11/05/22 download Created with Sketch. 315.64KB
IMC US DoD Uniformed Services University Clinical UpdatePRICE SENSITIVE09/05/22 download Created with Sketch. 301.1KB
IMC Appointment of Mr Steven Lydeamore as Chef Executive OfficerPRICE SENSITIVE05/05/22 download Created with Sketch. 292.96KB
IMC Immuron Q3 Global Sales up 216% YoYPRICE SENSITIVE27/04/22 download Created with Sketch. 267.71KB
IMC Immuron new MTEC project proposal19/04/22 download Created with Sketch. 344.8KB
IMC Initial Director's Interest Notice16/03/22 download Created with Sketch. 226.66KB
IMC Appointment of Paul Brennan as Non-Executive Director16/03/22 download Created with Sketch. 251.13KB
IMC Half Yearly Report and AccountsPRICE SENSITIVE25/02/22 download Created with Sketch. 3.23MB
IMC Response to ASX QueryPRICE SENSITIVE24/01/22 download Created with Sketch. 315.93KB
IMC Change in substantial holding24/01/22 download Created with Sketch. 854.54KB
IMC Immuron Receives AUD $306,154 R&D Tax Concession Refund17/01/22 download Created with Sketch. 224.4KB
IMC Immuron Receives European Patent on Drug to Treat DiarrheaPRICE SENSITIVE13/01/22 download Created with Sketch. 301.66KB
IMC Change in substantial holding
30/04/24 download Created with Sketch. 643.75KB
IMC Immuron CEO Steven Lydeamore to present at The Watchlist
23/04/24 download Created with Sketch. 1.83MB
IMC Immuron to host Live Virtual Event
15/04/24 download Created with Sketch. 296.16KB
IMC Immuron Travelan sales continued strong growth
10/04/24PRICE SENSITIVE download Created with Sketch. 315.78KB
IMC Change in substantial holding
22/03/24 download Created with Sketch. 1.51MB
IMC Notice under section 708A
14/03/24 download Created with Sketch. 179.38KB
IMC Change of Director's Interest Notice (DP)
14/03/24 download Created with Sketch. 168.99KB
IMC Application for quotation of securities - IMC
14/03/24 download Created with Sketch. 16.05KB
IMC Immuron CEO, Steven Lydeamore to present at Coffee Microcaps
14/03/24 download Created with Sketch. 1.29MB
IMC Change in substantial holding
14/03/24 download Created with Sketch. 1.49MB
IMC Travelan to progress to Phase 3 Clinical Trials in the US
07/03/24PRICE SENSITIVE download Created with Sketch. 408.71KB
IMC Trading Halt
05/03/24PRICE SENSITIVE download Created with Sketch. 221.96KB
IMC Change in substantial holding
01/03/24 download Created with Sketch. 1.52MB
IMC Appendix 4D and Half Year Report
28/02/24PRICE SENSITIVE download Created with Sketch. 2.93MB
IMC Presentation to Australian Biologics Festival 2024
21/02/24 download Created with Sketch. 2.48MB
IMC Immuron achieves record Travelan sales
13/02/24PRICE SENSITIVE download Created with Sketch. 260.27KB
IMC Investor Webinar Presentation
08/02/24 download Created with Sketch. 1.26MB
IMC Immuron achieves record half yearly Travelan sales
16/01/24PRICE SENSITIVE download Created with Sketch. 277.27KB
IMC Immuron Clinical Trials Update
22/12/23 download Created with Sketch. 292.74KB
IMC First Patients Enrolled in Campylobacter Clinical Study
04/12/23PRICE SENSITIVE download Created with Sketch. 303.92KB
IMC Investor Webinar Presentation
28/11/23 download Created with Sketch. 1.51MB
IMC Change of Director's Interest Notice (PB)
24/11/23 download Created with Sketch. 170.32KB
IMC Notification regarding unquoted securities - IMC
24/11/23 download Created with Sketch. 25.45KB
IMC Amended Constitution
22/11/23 download Created with Sketch. 463.37KB
IMC Results of Annual General Meeting
21/11/23 download Created with Sketch. 134.97KB
IMC Presentation to Annual General Meeting
21/11/23 download Created with Sketch. 774.11KB
IMC Investor Webinar Presentation
13/11/23 download Created with Sketch. 1.66MB
IMC Immuron CEO, Steven Lydeamore to present at AusBioInvest
30/10/23 download Created with Sketch. 1.36MB
IMC Notice of Annual General Meeting/Proxy Form
23/10/23 download Created with Sketch. 424.96KB
IMC Travelan Clinical Study Cohort 2 commences
18/10/23 download Created with Sketch. 303.18KB
IMC Immuron achieves record quarterly Travelan sales
11/10/23PRICE SENSITIVE download Created with Sketch. 279.1KB
IMC Immuron CEO, Steven Lydeamore to present at LD Micro
04/10/23 download Created with Sketch. 1.46MB
IMC Appendix 4G
28/09/23 download Created with Sketch. 263.25KB
IMC Corporate Governance Statement
28/09/23 download Created with Sketch. 199.71KB
IMC Annual Report to shareholders
28/09/23 download Created with Sketch. 4.04MB
IMC Immuron achieves record monthly Travelan sales
13/09/23PRICE SENSITIVE download Created with Sketch. 262.36KB
IMC Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
11/09/23 download Created with Sketch. 1.63MB
IMC Appendix 4E Preliminary Final Report
30/08/23PRICE SENSITIVE download Created with Sketch. 2.14MB
IMC Immuron present to Military Health System Research Symposium
14/08/23 download Created with Sketch. 453.76KB
IMC Immuron Receives TGA GMP Clearance
09/08/23PRICE SENSITIVE download Created with Sketch. 277.95KB
IMC Immuron enrols patients in Travelan clinical study
25/07/23PRICE SENSITIVE download Created with Sketch. 303.58KB
IMC Immuron CEO, Steven Lydeamore to present at Bioshares
24/07/23 download Created with Sketch. 1.65MB
IMC Notification regarding unquoted securities - IMC
12/07/23 download Created with Sketch. 27.28KB
IMC Letter to Shareholders
11/07/23 download Created with Sketch. 285.32KB
IMC Immuron FY23 Sales increase 136% on FY22 Sales
05/07/23PRICE SENSITIVE download Created with Sketch. 280.73KB
IMC Immuron Chairman Transition
30/06/23 download Created with Sketch. 255.93KB
IMC Letter to Shareholders
22/06/23 download Created with Sketch. 417.25KB
IMC Immuron CEO, Steven Lydeamore presents at LD Micro
07/06/23 download Created with Sketch. 1.8MB
IMC Immuron Initiates Recruitment of Travelan Clinical Study
30/05/23PRICE SENSITIVE download Created with Sketch. 297.14KB
IMC FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic
08/05/23PRICE SENSITIVE download Created with Sketch. 295.07KB
IMC IMC CEO Steven Lydeamore to present at Coffee Microcaps
02/05/23 download Created with Sketch. 998.52KB
IMC Q3 FY23 Business Update Presentation
19/04/23PRICE SENSITIVE download Created with Sketch. 866.7KB
IMC Q3 FY23 Business Update Webinar
11/04/23 download Created with Sketch. 285.87KB
IMC Immuron Q3 Sales reach 150% of 1H Sales
06/04/23PRICE SENSITIVE download Created with Sketch. 262.26KB
IMC Notification of cessation of securities - IMC
16/03/23 download Created with Sketch. 21.57KB
IMC Appendix 4D and Half Year Report
28/02/23PRICE SENSITIVE download Created with Sketch. 2.8MB
IMC Business Update Presentation
28/02/23PRICE SENSITIVE download Created with Sketch. 746.36KB
IMC Immuron CEO Steven Lydeamore to host investor webinar
15/02/23 download Created with Sketch. 211.84KB
IMC Immuron and US NMRC respond to CampETEC FDA Clinical Hold
25/01/23 download Created with Sketch. 252.86KB
IMC US DOD Travelan Clinical Recruitment Milestone
18/01/23 download Created with Sketch. 285.22KB
IMC Immuron Receives European Patent on Drug Composition
17/01/23 download Created with Sketch. 352.58KB
IMC Change in substantial holding
30/12/22 download Created with Sketch. 1.57MB
IMC Immuron Receives FDA Approval for Travelan IND Application
23/12/22PRICE SENSITIVE download Created with Sketch. 285.59KB
IMC Immuron Submits IND Application To FDA for Travelan
05/12/22 download Created with Sketch. 282.81KB
IMC Amended Constitution
01/12/22 download Created with Sketch. 496.22KB
IMC Results of Annual General Meeting
21/11/22 download Created with Sketch. 161.19KB
IMC AGM Presentation
21/11/22 download Created with Sketch. 534.76KB
IMC Immuron completes strategic investment in Ateria Health
16/11/22PRICE SENSITIVE download Created with Sketch. 323.13KB
IMC Immuron CEO Steven Lydeamore to present at AusBioInvest
26/10/22 download Created with Sketch. 645.88KB
IMC Notice of Annual General Meeting/Proxy Form
21/10/22 download Created with Sketch. 478.06KB
IMC IMC investment in leading gut health biotech Ateria Health
13/10/22PRICE SENSITIVE download Created with Sketch. 343.35KB
IMC Immuron Executes Travelan Clinical Trial Agreement Pharmaron
04/10/22 download Created with Sketch. 284.86KB
IMC Appendix 4G
09/09/22 download Created with Sketch. 323.73KB
IMC Corporate Governance Statement
09/09/22 download Created with Sketch. 201.39KB
IMC Annual Report to shareholders
09/09/22 download Created with Sketch. 3.86MB
IMC FY22 Results and Business Update Presentation
31/08/22 download Created with Sketch. 881.7KB
IMC Appendix 4E and Preliminary Final Report
31/08/22PRICE SENSITIVE download Created with Sketch. 1.46MB
IMC Immuron CEO, Steven Lydeamore, to host an investor webinar
29/08/22 download Created with Sketch. 281.17KB
IMC Immuron Update on IMM-124E SARS-CoV-2 Research
19/08/22PRICE SENSITIVE download Created with Sketch. 284.76KB
IMC Update on IND Application for Campylobacter ETEC Therapeutic
26/07/22 download Created with Sketch. 285.31KB
IMC North American Travelan Sales up 494%, Global sales up 431%
11/07/22PRICE SENSITIVE download Created with Sketch. 258.28KB
IMC European Patent Notification on Drug Composition for CDI
07/07/22PRICE SENSITIVE download Created with Sketch. 388.35KB
IMC Change of Director's Interest Notice (DP)
04/07/22 download Created with Sketch. 182.63KB
IMC Notification regarding unquoted securities - IMC
01/07/22 download Created with Sketch. 25.37KB
IMC Change of Director's Interest Notice
15/06/22 download Created with Sketch. 191.78KB
IMC Notification of cessation of securities - IMC
14/06/22 download Created with Sketch. 21.61KB
IMC Notification of cessation of securities - IMC
10/06/22 download Created with Sketch. 22.1KB
IMC Change in substantial holding
25/05/22 download Created with Sketch. 889.62KB
IMC US DoD NMRC files IND application with FDA
11/05/22PRICE SENSITIVE download Created with Sketch. 315.64KB
IMC US DoD Uniformed Services University Clinical Update
09/05/22PRICE SENSITIVE download Created with Sketch. 301.1KB
IMC Appointment of Mr Steven Lydeamore as Chef Executive Officer
05/05/22PRICE SENSITIVE download Created with Sketch. 292.96KB
IMC Immuron Q3 Global Sales up 216% YoY
27/04/22PRICE SENSITIVE download Created with Sketch. 267.71KB
IMC Immuron new MTEC project proposal
19/04/22 download Created with Sketch. 344.8KB
IMC Initial Director's Interest Notice
16/03/22 download Created with Sketch. 226.66KB
IMC Appointment of Paul Brennan as Non-Executive Director
16/03/22 download Created with Sketch. 251.13KB
IMC Half Yearly Report and Accounts
25/02/22PRICE SENSITIVE download Created with Sketch. 3.23MB
IMC Response to ASX Query
24/01/22PRICE SENSITIVE download Created with Sketch. 315.93KB
IMC Change in substantial holding
24/01/22 download Created with Sketch. 854.54KB
IMC Immuron Receives AUD $306,154 R&D Tax Concession Refund
17/01/22 download Created with Sketch. 224.4KB
IMC Immuron Receives European Patent on Drug to Treat Diarrhea
13/01/22PRICE SENSITIVE download Created with Sketch. 301.66KB
(20min delay)
Last
10.0¢
Change
0.000(0.00%)
Mkt cap ! $22.8M
Open High Low Value Volume
10.0¢ 10.0¢ 9.9¢ $16.68K 166.8K

Buyers (Bids)

No. Vol. Price($)
1 29183 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 249372 10
View Market Depth
Last trade - 15.40pm 30/04/2024 (20 minute delay) ?
Last
10.0¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
10.0¢ 10.0¢ 10.0¢ 45446
Last updated 15.40pm 30/04/2024 ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.